In DOTS classification, an adverse effect occurring at supratherapeutic concentrations is described as:

In DOTS classification, an adverse effect occurring at supratherapeutic concentrations is described as:

• A. Allergic reaction
• B. Toxic effects
• C. Tolerance
• D. Pharmacokinetic interaction

Answer: (B)

In the DoTS framework, adverse effects are analyzed by the relationship between the dose and the response. If an effect appears when the drug concentration is above the therapeutic range—i.e., at supratherapeutic levels—the proper term is toxic effects. This classification reflects a dose-related toxicity rather than an immune reaction, a tolerance phenomenon, or an interaction between drugs. Allergic reactions are immune-mediated responses that can occur at any dose and are not due to being supratherapeutic. Tolerance describes a reduced response to a drug over time with repeated exposure, not an effect caused by a high concentration. Pharmacokinetic interactions involve one drug altering the levels of another, which is about interactions between drugs rather than the effect produced by an excessive dose itself.

In the DoTS framework, adverse effects are analyzed by the relationship between the dose and the response. If an effect appears when the drug concentration is above the therapeutic range—i.e., at supratherapeutic levels—the proper term is toxic effects. This classification reflects a dose-related toxicity rather than an immune reaction, a tolerance phenomenon, or an interaction between drugs.

Allergic reactions are immune-mediated responses that can occur at any dose and are not due to being supratherapeutic. Tolerance describes a reduced response to a drug over time with repeated exposure, not an effect caused by a high concentration. Pharmacokinetic interactions involve one drug altering the levels of another, which is about interactions between drugs rather than the effect produced by an excessive dose itself.